Detalhe da pesquisa
1.
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China.
Cost Eff Resour Alloc
; 19(1): 46, 2021 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348729
2.
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge.
Value Health
; 23(9): 1163-1170, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940234
3.
Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
Biochem J
; 468(3): 485-93, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25851527
4.
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom.
J Med Econ
; 27(1): 777-785, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758099
5.
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States.
J Manag Care Spec Pharm
; 29(7): 807-817, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133431
6.
The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark.
Diabetes Ther
; 13(3): 489-503, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187628
7.
The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark.
J Comp Eff Res
; 11(1): 29-37, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841893
8.
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
Med Decis Making
; 42(5): 599-611, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911405
9.
Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China.
BMJ Open
; 11(4): e043664, 2021 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910947
10.
Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy.
Diabetes Ther
; 12(12): 3231-3241, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714524
11.
Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China.
J Comp Eff Res
; 10(6): 469-480, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576249
12.
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal.
Rev Port Cardiol (Engl Ed)
; 40(2): 109-115, 2021 Feb.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-33581948
13.
Multicenter Prospective Evaluation of Parenteral Nutrition Preparation Time and Resource Utilization: 3-Chamber Bags Compared With Hospital Pharmacy-Compounded Bags.
JPEN J Parenter Enteral Nutr
; 45(7): 1552-1558, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188572
14.
Cost-effectiveness of empagliflozin compared with liraglutide based on cardiovascular outcome trials in Type II diabetes.
J Comp Eff Res
; 9(11): 781-794, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573253
15.
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK.
Diabetes Ther
; 11(9): 2041-2055, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700188
16.
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease.
Diabetes Ther
; 10(6): 2153-2167, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31602601
17.
Cost-effectiveness of physical activity in the management of COPD patients in the UK.
Int J Chron Obstruct Pulmon Dis
; 14: 227-239, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30697043
18.
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients.
J Med Econ
; 22(4): 289-296, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547704
19.
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach.
Value Health Reg Issues
; 18: 36-46, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419449
20.
Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico.
Value Health Reg Issues
; 17: 164-173, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30317158